Bonato V, Barni R, Cataldo D, Collini A, Ruggieri G, De Bartolomeis C, Dotta F, Carmellini M
UOC Diabetologia, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
Transplant Proc. 2008 Jul-Aug;40(6):1888-90. doi: 10.1016/j.transproceed.2008.05.045.
The onset of posttransplant diabetes mellitus (PTDM) among kidney recipients is associated with an increased risk of graft failure and death. Minimizing the risk of PTDM is a priority for long-term improvement in survival rates. We sought to evaluate the prevalence of PTDM and impaired fasting glucose (IFG) among a population of kidney transplant recipients to identify the risk factors and to evaluate graft and patient survivals.
We analyzed 250 consecutive Caucasian patients who received kidney allografts in our center between May 2000 and December 2005, with a median follow-up of 32 months (range, 1-78 months).
We observed altered glucose metabolism in 17% of patients; specifically, the prevalences of PTDM and IFG were 12.2% and 4.8%, respectively. Patients who developed PTDM or IFG were overweight (BMI, 26.4+/-3.4 and 28.1+/-3.4 kg/m(2), respectively), whereas the normal glucose (NG) group's BMI was 23.8+/-3.5 kg/m(2) (P= .002 and P= .004, respectively). Prevalence of acute rejection was higher in the PTDM and IFG patients compared with the NG patients (60.7%, 63.6%, and 32.1%, respectively; P= .006; P< .04), while no difference was observed in terms of graft and patient overall survival.
In our series of patients, we showed that being overweight represents a major risk factor for the development of PTDM, which results in an increased acute rejection rate. These results confirmed the importance of appropriate weight control among patients undergoing kidney transplantation, which should also be strictly monitored for all risk factors associated with the development of impaired glucose metabolism.
肾移植受者中移植后糖尿病(PTDM)的发生与移植失败和死亡风险增加相关。将PTDM风险降至最低是长期提高生存率的首要任务。我们旨在评估肾移植受者群体中PTDM和空腹血糖受损(IFG)的患病率,以确定风险因素并评估移植肾和患者的生存率。
我们分析了2000年5月至2005年12月期间在本中心接受同种异体肾移植的250例连续的白种人患者,中位随访时间为32个月(范围1 - 78个月)。
我们观察到17%的患者存在糖代谢改变;具体而言,PTDM和IFG的患病率分别为12.2%和4.8%。发生PTDM或IFG的患者超重(BMI分别为26.4±3.4和28.1±3.4kg/m²),而血糖正常(NG)组的BMI为23.8±3.5kg/m²(P分别为0.002和0.004)。与NG患者相比,PTDM和IFG患者的急性排斥反应患病率更高(分别为60.7%、63.6%和32.1%;P = 0.006;P < 0.04),而在移植肾和患者总体生存率方面未观察到差异。
在我们的患者系列中,我们表明超重是发生PTDM的主要风险因素,这导致急性排斥反应率增加。这些结果证实了肾移植患者适当控制体重的重要性,同时也应对所有与糖代谢受损发展相关的风险因素进行严格监测。